Welcome back, Rounds Table Listeners! This week we have a solo episode with Dr. John Fralick, discussing a recently published trial of the GLP-1 receptor agonist semaglutide for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). Here we go!
The Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
